Programmed Cell Death 4 inhibits breast cancer cell invasion by increasing Tissue Inhibitor of Metalloproteinases-2 expression

Breast Cancer Research and Treatment

Volumn 114, Issue 2, 2009, Pages 203-209

  Nieves Alicea, René ^a   Colburn, Nancy H ^b   Simeone, Ann Marie ^a   Tari, Ana M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer invasion; Interleukin 8; Programmed Cell Death 4; Prostaglandin E2; Tissue Inhibitor of Metalloproteinase 2

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 8; MESSENGER RNA; PROGRAMMED CELL DEATH 4 PROTEIN; PROSTAGLANDIN E2; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER INVASION; CELL INVASION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG DOSE INCREASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; BREAST NEOPLASMS; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED;

EID: 59449100493     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-9993-5     Document Type: Article

References (34)

1. Ries L, Melbert D, Krapcho M et al (2007) SEER Cancer Statistic Review, 1975-2004, National Cancer Institute. Bethesda, MD. Available via INTERNET http://seer.cancer.gov/csr/1975-2004/, based on November 2006 SEER data submission, posted to the SEER web site, 2007. Cited 2 Feb 2007
2. C Denkert KJ Winzer BM Muller 2003 Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma Cancer 97 12 2978 2987
3. A Ristimaki A Sivula J Lundin 2002 Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer Cancer Res 62 3 632 635
4. RA Soslow AJ Dannenberg D Rush 2000 COX-2 is expressed in human pulmonary, colonic, and mammary tumors Cancer 89 12 2637 2645
5. TL Larkins M Nowell S Singh 2006 Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression BMC Cancer 6 181 193
6. AM Simeone R Nieves-Alicea VC McMurtry 2007 Cyclooxygenase-2 uses the protein kinase C/interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells Int J Oncol 30 4 785 792
7. B Singh JA Berry A Shoher 2005 COX-2 overexpression increases motility and invasion of breast cancer cells Int J Oncol 26 5 1393 1399
8. Z Zhang RN DuBois 2001 Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor Oncogene 20 33 4450 4456
9. HS Yang AP Jansen R Nair 2001 A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation Oncogene 20 6 669 676
10. JL Cmarik H Min G Hegamyer 1999 Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation Proc Natl Acad Sci USA 96 24 14037 14042
11. AP Jansen CE Camalier NH Colburn 2005 Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis Cancer Res 65 14 6034 6041
12. HS Yang AP Jansen AA Komar 2003 The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation Mol Cell Biol 23 1 26 37
13. R Goke P Barth A Schmidt 2004 Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1) Am J Physiol Cell Physiol 287 6 C1541 C1546
14. AP Jansen CE Camalier C Stark 2004 Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity Mol Cancer Ther 3 2 103 110
15. Y Chen T Knosel G Kristiansen 2003 Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis J Pathol 200 5 640 646
16. G Ma KJ Guo H Zhang 2005 Expression of programmed cell death 4 and its clinicopathological significance in human pancreatic cancer Zhongguo Yi Xue Ke Xue Yuan Xue Bao 27 5 597 600
17. H Zhang I Ozaki T Mizuta 2006 Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma Oncogene 25 45 6101 6112
18. G Mudduluru F Medved R Grobholz 2007 Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer Cancer 110 8 1697 1707
19. F Gao P Zhang C Zhou 2007 Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma Oncol Rep 17 1 123 128
20. YH Wen X Shi L Chiriboga 2007 Alterations in the expression of PDCD4 in ductal carcinoma of the breast Oncol Rep 18 6 1387 1393
21. JH Leupold HS Yang NH Colburn 2007 Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors Oncogene 26 31 4550 4562
22. HS Yang CP Matthews T Clair 2006 Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion Mol Cell Biol 26 4 1297 1306
23. Q Wang Z Sun HS Yang 2008 Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells Oncogene 27 11 1527 1535
24. AM Tari AM Simeone YJ Li 2005 Cyclooxygenase-2 protein reduces tamoxifen and N-(4-hydroxyphenyl)retinamide inhibitory effects in breast cancer cells Lab Invest 85 11 1357 1367
25. SM Ahn SJ Jeong YS Kim 2004 Retroviral delivery of TIMP-2 inhibits H-ras-induced migration and invasion in MCF10A human breast epithelial cells Cancer Lett 207 1 49 57
26. T Yoneda A Sasaki C Dunstan 1997 Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2 J Clin Invest 99 10 2509 2517
27. MG Sacco EM Cato R Ceruti 2001 Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice Gene Ther 8 1 67 70
28. AH Ree VA Florenes JP Berg 1997 High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases Clin Cancer Res 3 9 1623 1628
29. FJ Vizoso LO Gonzalez MD Corte 2007 Study of matrix metalloproteinases and their inhibitors in breast cancer Br J Cancer 96 6 903 911
30. Y Jiang ID Goldberg YE Shi 2002 Complex roles of tissue inhibitors of metalloproteinases in cancer Oncogene 21 14 2245 2252
31. NV Dorrello A Peschiaroli D Guardavaccaro 2006 S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth Science 314 5798 467 471
32. B Ozpolat U Akar M Steiner 2007 Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells Mol Cancer Res 5 1 95 108
33. LB Frankel NR Christoffersen A Jacobsen 2008 Programmed Cell Death 4 (PDCD4) is an important functional target of the MicroRNA miR-21 in breast cancer cells J Biol Chem 283 2 1026 1033
34. Asangani IA, Rasheed SA, Nikolova DA, et al (2007) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. Advance online publication October 29